Our results also indicated that activation of FZD1/Wnt signaling plays an essential role in the development of cardiac hypotrophy in the post-MI, and that RFP may provide an interesting therapeutic strategy to reduce the endogenous expression of FZD1, thus protects against cardiac hypertrophy. This evidence concerns the gene FZD1 and myocardial infarction.